AIDS 2026 - International AIDS Conference

AIDS 2026, the 26th International AIDS Conference, will take place in Rio de Janeiro, Brazil, from 26 to 31 July 2026, in the Riocentro (Barra da Tijuca).

Main points

The International AIDS Society (IAS) is organising the 26th edition of the International AIDS Conference this year.

The conference will bring together people living with HIV, researchers, policy-makers, healthcare professionals, donors, the media and communities, centred on the theme: “Rethink. Rebuild. Rise.” “

On this year’s programme, you’ll find the ANRS MIE:

  • at the symposium organised by the Rhiviera consortium on the theme “Treatment interruption and resumption: lessons learnt from clinical trials on HIV cure”;
  • at the France stand through round-table discussions, meetings and Q&A sessions;
  • and through the agency’s supported research, which will inform various sessions.

AIDS 2026 is taking place in a context marked by major developments in the HIV response, particularly regarding programme funding and organisation. This event represents an important opportunity to analyse ongoing dynamics and identify future priorities.

The conference will highlight the conditions needed to sustain scientific and operational progress in the fight against HIV. It will provide a forum for discussion on issues related to research, clinical trials and the integration of scientific knowledge into health strategies.

In this context, AIDS 2026 will be structured around five strategic priorities aimed at supporting innovation, strengthening prevention approaches and promoting the implementation of coordinated responses:

  1. Accelerate innovation in basic and clinical science, spanning research into reducing HIV acquisition and transmission, developing immunotherapeutics and vaccines, understanding pathogenesis, improving treatment options, managing co-infections, co-morbidities and ageing-related issues, and advancing towards a cure and/or sustained remission strategies.
  2. Enhance HIV prevention to optimize cost-effective biomedical, behavioural and structural interventions, with special attention on identifying and overcoming implementation challenges and scaling successful HIV prevention strategies.
  3. Advance interdisciplinary collaboration in programme implementation to improve HIV outcomes across all life stages, with emphasis on translating research findings into actionable policies and practices.
  4. Promote a human rights-based and evidence-informed HIV response that is tailored to the needs of key and vulnerable populations, protects civil society spaces and strengthens community resilience.
  5. Discuss the most recent HIV science and policy in the Americas, empowering regional actors to actively contribute and disseminate their findings and experiences globally and integrate firmly into global HIV networks.
Learn more about AIDS 2026

Rhiviera consortium satellite symposium

Organised by the ANRS RHIVIERA consortium, this satellite symposium will focus on the theme: “Treatment interruption and treatment resumption: lessons learned from HIV cure clinical trials.” It will take place on 30 July, from 6:00 to 7:30 p.m. in Room 205.

This satellite will explore current advances and challenges in analytical treatment interruption (ATI) research as a means to understand post-ART viral dynamics.

Drawing on findings from RHIVIERA and other international studies, the session will examine the immunovirological mechanisms underlying viral rebound and post-treatment control, the evolution of infection after ART resumption, and the lived experience of study participants.

By integrating insights from diverse ATI studies and therapeutic trials, the workshop aims to foster dialogue between clinicians, researchers, and community representatives, and to identify emerging therapeutic opportunities that may pave the way toward sustained HIV remission.

Read the programme

Meet ANRS MIE at the France stand

The agency will be present at the France stand alongside our partners: the Ministry for Europe and Foreign Affairs, the IRD, Expertise France and Santé publique France.

Programme for the France stand:

Tuesday, 10.30 am – 11.30 am – Official opening of the France stand

Tuesday, 1.00 pm – 2.00 pm – Round table – ANRS MIE

  • Franco-Brazilian scientific cooperation in health: Focus on key projects and meeting with partners of the France-Brazil PRISME initiative

Tuesday, 3.30 pm – 4.30 pm – Meeting – ANRS MIE

  • Meeting with the winners of the IAS / ANRS Lange / van Tongeren Prize for young researchers. With Yazdan Yazdanpanah, Director of ANRS MIE.

Wednesday, 10.00 am – 11.00 am – Round table

  • Innovation and access to innovation

Wednesday, 1.00 pm – 2.00 pm – Round table

  • Health sovereignty in the fight against HIV/AIDS

Wednesday, 3.30 pm – 4.30 pm – Roundtable – The Initiative

  • Key and vulnerable populations

Thursday, 10.00 am – 11.00 am – Roundtable – Ministry of Health & Santé publique France

  • Prevention, surveillance and action

Thursday, 1.00 pm – 2.00 pm – Q&A session – ANRS MIE

  • As research into a cure for HIV progresses, what must we do to ensure an equitable impact?

Thursday, 2.30 pm – 3.30 pm – Meeting – ANRS MIE

  • Meeting with ANRS MIE: presentation of the International Network and presentation of the agency’s calls for projects and funding opportunities

Research supported by ANRS MIE and presented at the AIDS 2026 conference

Title
Presented by

RHIVIERA-01: analytical treatment interruption in early-treated people with B35(53)-Bw4TTC2 genotype – Oral presentation

Asier Saez-Cirion

Back to PrEP à Porter: addressing lost to follow-up participants in a community-based multidisciplinary PrEP implementation strategy for trans women in Paris – Oral presentation

Frederico Pipitone

Innate immune signatures of post-interventional control in very early-treated women living with clade C HIV (FRESH cohort) – Oral presentation

Yanis Merad

Cytotoxic CX3CR1high resident memory CD8+ T cells contain most of HIV-1-specific cells but are depleted in the colonic mucosa of people with HIV on ART – Poster

Nived Collercandy

Identifying a high-risk period for suicide attempts among transgender women living with HIV (ANRS-Trans&HIV) – Poster

Raymond Van Huizen

“I truly felt like a woman”: Impact of integrated gender-affirming care on acceptability of PrEP à Porter, a community‑based multidisciplinary PrEP implementation strategy for transgender women in Paris – Poster

Federico Pipitone

“You take what I take, so you’re dead”: external and internal HIV stigma in migrant transfeminine communities in Paris in the age of PrEP – Poster

Clark Pignedoli

Violence, housing instability, and undocumented status: social adversity and suicide attempts among transgender women living with HIV (ANRS-Trans&HIV) – Poster

Bruno Spire

Inflammatory profile of memory NK cells is associated to low titers of yellow fever neutralizing antibodies after one year of vaccination in PLWHIV and non-HIV individuals – ANRS12403 – Poster

Carmem Beatriz Wagner Giacoia-Gripp